登录 | 注册    关注公众号  
微信公众号
搜索
 >  Cell>STAT3 >CHEK-ATF047

STAT3 (Luc) HEK293 Reporter Cell

For research use only.

描述(Description)

The STAT3 (Luc) HEK293 Reporter Cell was engineered with the STAT3 response element driving luciferase expressing systems. The receptors expressing endogenously or transfected on this reporter cell were activated by corresponding ligands binding, transducing intracellular signals resulting in STAT3-RE mediated luminescence.

应用说明(Application)

• The discovery of activators or inhibitors by the STAT3 signaling bioactivity.

• Transfection host for some receptors concerning the STAT3 signaling pathway.

STAT3 Assay Principles

生长特性(Growth Properties)

Adherent

筛选标记(Selection Marker)

Hygromycin (40 μg/mL)

培养基(Culture Medium)

DMEM medium + 10% FBS

冻存液(Freeze Medium)

Serum-free cell cryopreservation medium

装量(Quantity)

1 vial contains at least 5×10^6 cells in 1 mL serum-free cryopreservation medium

存储(Storage)

Frozen in liquid nitrogen.

支原体检测(Mycoplasma Testing)

Negative

无菌检测(Sterility Testing)

Negative

使用说明(Instructions for Use)

See data sheet for detailed culturing and assay protocol.

 

Application

STAT3 APPLICATION

Inhibition of human IL-6 protein-induced reporter activity by anti-human IL-6 neutralizing antibody.
This reporter cell was incubated with serial dilutions of antibodies in the presence of human IL-6 protein (AcroBiosystems, Cat.No.IL6-H4218) with a final concentration of 2.5 ng/mL. The EC50 of anti-human IL-6 neutralizing antibody is approximately 0.04 μg/mL.

Protocol

STAT3 APPLICATION

Inhibition of human IL-6 protein-induced reporter activity by JAK inhibitor.
This reporter cell was incubated with serial dilutions of JAK inhibitors in the presence of human IL-6 protein with a final concentration of 2.5 ng/mL. The EC50 of JAK inhibitor (Baricitinib) was approximately 0.0108 μM.

Protocol

 

Signaling Bioassay

STAT3 SIGNALING

Response to human IL-6 protein (RLU).
The STAT3 (Luc) HEK293 Reporter Cell was stimulated with serial dilutions of human IL-6 protein (AcroBioystems, Cat.No.IL6-H4218). The EC50 was approximately 2.2 ng/mL.

Protocol

STAT3 SIGNALING

Response to human IL-6 protein (Fold).
The STAT3 (Luc) HEK293 Reporter Cell was stimulated with serial dilutions of human IL-6 protein (AcroBiosystems, Cat.No.IL6-H4218). The max induction fold was approximately 100.5.

Protocol

 

Passage Stability

STAT3 PASSAGE

Passage stability analysis by Signaling Bioassay.
The continuously growing STAT3 (Luc) HEK293 Reporter Cell was stimulated with serial dilutions of human IL-6 protein. Human IL-6 protein stimulated response demonstrates passage stabilization (fold induction and EC50) across passage 9-37.

Protocol

如有相关细胞池需求请联系我们

 

背景(Background)

Signal transducer and activator of transcription 3 (STAT3) regulates the expression of genes important for essential cellular processes including survival, proliferation, self-renewal, angiogenesis, and immune response. As an early tumor diagnostic marker, it is considered that constitutive STAT3 activation is a sufficient factor to cause malignant transformation and tumor development in model systems. The classical IL-6/STAT3 signaling pathway in cancer cells. IL-6 binds to the membrane-bound IL-6 receptor α (IL-6R) and IL-6 receptor β (also known as gp130). The IL-6/IL-6R/gp130 complex activate the phosphorylation of JAKs, followed by STAT3 phosphorylation and activation. Then, phosphorylated STAT3 forms a homodimer and translocates into the nucleus to bind to the promotor region of target genes and activates target gene transcription.

 

License Disclosure

This cell line is provided for research use only. This license does not permit you to share, distribute, sell, sublicense, or otherwise make this cell line available for use to other laboratories, departments, research institutions, hospitals, universities, or biotech companies. The license does not permit modification of this cell line in any way. Inappropriate use or distribution of this cell line will result in revocation of the license. Modifications of this cell line, transfer to another facility, or commercial use of the cell lines may require a separate license and additional fees. AcroBiosystems does not warrant the suitability of this cell line for any particular use, and does not accept any liability in connection with the handling or use of this cell line.

 

前沿进展

 
 
货号/价格
文档
联系电话:
+86 400-682-2521(全国)
010-53681107(北京)
021-50850665(上海)
运输方式
订单邮箱:
order.cn@acrobiosystems.com
技术支持邮箱:
tech.cn@acrobiosystems.com
STAT3靶点信息
英文全称:Signal transducer and activator of transcription 3
中文全称:信号转导和转录激活因子-3
种类:Homo sapiens
上市药物数量:2详情
临床药物数量:20详情
最高研发阶段:批准上市
查看更多信息
前沿进展
点击查看详细

消息提示

请输入您的联系方式,再点击提交!

确定